LM Advisors LLC Sells 7,814 Shares of SPDR S&P Biotech ETF $XBI

LM Advisors LLC decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 89.2% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 946 shares of the exchange traded fund’s stock after selling 7,814 shares during the period. LM Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $115,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Dynamic Wealth Strategies LLC grew its holdings in shares of SPDR S&P Biotech ETF by 3.8% in the fourth quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock worth $268,000 after purchasing an additional 80 shares during the last quarter. Capital Investment Advisory Services LLC grew its holdings in shares of SPDR S&P Biotech ETF by 4.0% in the fourth quarter. Capital Investment Advisory Services LLC now owns 2,123 shares of the exchange traded fund’s stock worth $259,000 after purchasing an additional 81 shares during the last quarter. Commerce Bank grew its holdings in shares of SPDR S&P Biotech ETF by 2.8% in the fourth quarter. Commerce Bank now owns 3,260 shares of the exchange traded fund’s stock worth $397,000 after purchasing an additional 90 shares during the last quarter. Compass Ion Advisors LLC grew its holdings in shares of SPDR S&P Biotech ETF by 2.6% in the fourth quarter. Compass Ion Advisors LLC now owns 3,886 shares of the exchange traded fund’s stock worth $474,000 after purchasing an additional 97 shares during the last quarter. Finally, Moors & Cabot Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 3.8% in the third quarter. Moors & Cabot Inc. now owns 2,717 shares of the exchange traded fund’s stock worth $272,000 after purchasing an additional 100 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $133.79 on Friday. SPDR S&P Biotech ETF has a 52-week low of $80.90 and a 52-week high of $139.19. The stock has a market capitalization of $8.54 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. The company’s 50 day moving average price is $132.63 and its 200-day moving average price is $127.12.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.